Regeneron Pharmaceuticals Crashes 19% On A Surprise Sanofi-Tied Failure
Regeneron Pharmaceuticals Crashes 19% On A Surprise Sanofi-Tied Failure · Investor's Business Daily

In This Article:

Regeneron stock crashed Friday after the company's Sanofi-partnered COPD treatment unexpectedly failed in a Phase 3 study.